Century Link Investment Management CO Amgen Inc Transaction History

Century Link Investment Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$197.81 - $242.74 $1.69 Million - $2.07 Million	-8,537 Closed	0 $0
Q4 2019 Jan 13, 2020	SELL	$189.21 - $243.2 $251,838 - $323,699	-1,331 Reduced 13.49%	8,537 $2.06 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $291,111 - $348,812	-1,672 Reduced 14.49%	9,868 $1.91 Million
Q1 2019 Apr 04, 2019	SELL	$180.87 - $203.88 $97,488 - $109,891	-539 Reduced 4.46%	11,540 $2.19 Million
Q4 2018 Jan 04, 2019	SELL	$178.4 - $208.25 $53,341 - $62,266	-299 Reduced 2.42%	12,079 $2.35 Million
Q3 2018 Oct 09, 2018	SELL	$185.29 - $208.89 $274,599 - $309,574	-1,482 Reduced 10.69%	12,378 $2.57 Million
Q2 2018 Jul 05, 2018	SELL	$166.05 - $186.51 $166,714 - $187,256	-1,004 Reduced 6.75%	13,860 $2.56 Million
Q4 2017 Jan 08, 2018	SELL	$168.79 - $188.59 $351,251 - $392,455	-2,081 Reduced 12.28%	14,864 $2.59 Million
Q3 2017 Oct 06, 2017	BUY	$167.29 - $191.0 $2.83 Million - $3.24 Million	16,945	16,945 $3.16 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Century Link Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Century Link Investment Management CO with notifications on news.